"Gilead wins positive European approval opinion for twice-yearly HIV injection" was originally created and published by ...

The EU's medicines regulator said it would approve the treatment for a limited group of patients, citing concerns over side effects ...

A key advantage of the drug is its oral route of administration, offering patients a more convenient alternative to ...

The drug targets the overgrowth of synovial cells and inflammatory components that drive tumor development and joint ...

EMA encourages NAMs to replace animal testing, aligning with 3Rs principles, and has published a concept paper on regulatory ...

The European Medicines Agency (EMA) cleared the way for the use of another drug to treat Alzheimer's disease on Friday.

LONDON (AP) — The European Medicines Agency has recommended authorizing a twice-yearly injectable drug aimed at preventing ...

The European Union's drug regulator has recommended approval of Moderna's updated formulation of COVID-19 shot Spikevax, the ...

Lilly’s appeal of an earlier, negative recommendation from a key EMA committee has worked out in its favor, and puts the drug ...

Eli Lilly said on Friday that the European Medicines Agency (EMA) has recommended approval of its drug Kisunla for certain ...

European regulators said that Eli Lilly’s Alzheimer’s treatment Kisunla should be approved for select patients.